NASDAQ:STAA STAAR Surgical - STAA Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding STAAR Surgical Please log in to your account or sign up in order to add this asset to your watchlist. $72.26 -2.38 (-3.19%) (As of 02/8/2023 12:00 AM ET) Add Compare Share Share Today's Range$72.11▼$75.2350-Day Range$46.82▼$79.3452-Week Range$46.35▼$112.27Volume268,475 shsAverage Volume863,530 shsMarket Capitalization$3.48 billionP/E Ratio95.08Dividend YieldN/APrice Target$82.70 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability STAAR Surgical MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside14.4% Upside$82.70 Price TargetShort InterestBearish9.83% of Shares Sold ShortDividend StrengthN/ASustainability-0.73Upright™ Environmental ScoreNews Sentiment0.09Based on 17 Articles This WeekInsider TradingAcquiring Shares$4.36 M Bought Last QuarterProj. Earnings Growth22.89%From $0.83 to $1.02 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.66 out of 5 starsMedical Sector73rd out of 1,026 stocksOphthalmic Goods Industry1st out of 7 stocks 3.4 Analyst's Opinion Consensus RatingSTAAR Surgical has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $82.70, STAAR Surgical has a forecasted upside of 14.4% from its current price of $72.26.Amount of Analyst CoverageSTAAR Surgical has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.83% of the outstanding shares of STAAR Surgical have been sold short.Short Interest Ratio / Days to CoverSTAAR Surgical has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in STAAR Surgical has recently increased by 14.22%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSTAAR Surgical does not currently pay a dividend.Dividend GrowthSTAAR Surgical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSTAAR Surgical has received a 58.64% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Intraocular lenses" product. See details.Environmental SustainabilityThe Environmental Impact score for STAAR Surgical is -0.73. Previous Next 1.7 News and Social Media Coverage News SentimentSTAAR Surgical has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for STAAR Surgical this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of -44% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STAAR Surgical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,364,185.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.60% of the stock of STAAR Surgical is held by insiders.Percentage Held by Institutions97.55% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for STAAR Surgical are expected to grow by 22.89% in the coming year, from $0.83 to $1.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STAAR Surgical is 95.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 151.02.Price to Earnings Ratio vs. SectorThe P/E ratio of STAAR Surgical is 95.08, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 165.27.Price to Book Value per Share RatioSTAAR Surgical has a P/B Ratio of 13.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About STAAR Surgical (NASDAQ:STAA) StockSTAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.Read More Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address STAA Stock News HeadlinesFebruary 8, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Stock Rating Lowered by BTIG ResearchFebruary 7, 2023 | finance.yahoo.comSTAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023February 9, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.February 6, 2023 | seekingalpha.comSTAAR Surgical downgraded to neutral at BTIG on Chinese economy uncertaintyFebruary 6, 2023 | markets.businessinsider.comStaar Surgical (STAA) was downgraded to a Hold Rating at BTIGFebruary 3, 2023 | finance.yahoo.comStaar Surgical (STAA) Dips More Than Broader Markets: What You Should KnowFebruary 3, 2023 | finance.yahoo.comSTAAR Surgical (STAA) to Report Q4 Earnings: What's in Store?February 3, 2023 | finance.yahoo.comSTAAR Surgical Company (STAA) Is a Trending Stock: Facts to Know Before Betting on ItFebruary 9, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.February 2, 2023 | marketwatch.comIntraocular Lens (IOL) Material Market Dynamics with Top Players, Gross Margin, Regional Demand, Plans and Demand Status Forecast to 2028February 2, 2023 | americanbankingnews.comBenchmark Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $75.00February 2, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) PT Raised to $80.00January 24, 2023 | benzinga.comAnalyst Reiterates This Ophthalmology Device Stock On Steep But Attractive Risk/RewardJanuary 24, 2023 | markets.businessinsider.comNeedham Keeps Their Buy Rating on Staar Surgical (STAA)January 17, 2023 | finance.yahoo.comStaar Surgical (STAA) Gains As Market Dips: What You Should KnowJanuary 17, 2023 | nz.finance.yahoo.comMinimally Invasive Cataract Surgery Devices Market is expected to grow from USD 5.5 billion in 2022 to USD 47.7 billion by 2030 : GreyViewsJanuary 13, 2023 | marketwatch.comOphthalmic Devices Market Transforming the Global Industry LandscapeJanuary 13, 2023 | marketwatch.comOphthalmic Instrumentation Market Growth, Size, Share, Opportunities, Industry Analysis and Forecast 2023 To 2028January 11, 2023 | marketwatch.comOphthalmology Surgical Devices Market Size, Sales, CAGR And Competition Data from 2023 To 2028January 11, 2023 | finance.yahoo.comActress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL LensesJanuary 10, 2023 | marketwatch.comOphthalmology Cataract Surgery Devices Market : Research Report Analysis by Competitors, Sales, Revenue and Industry Size 2023 To 2028January 10, 2023 | markets.businessinsider.comNeedham Reaffirms Their Hold Rating on Sight Sciences (SGHT)January 10, 2023 | finance.yahoo.comHere's Why STAAR Surgical (NASDAQ:STAA) Has Caught The Eye Of InvestorsJanuary 9, 2023 | msn.comSTAAR Surgical stock falls after guiding sales lower than estimatesJanuary 9, 2023 | markets.businessinsider.comSTAAR Surgical Company Updates FY23 Net Sales OutlookJanuary 9, 2023 | finance.yahoo.comSTAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022January 6, 2023 | fool.comWhy Shares of STAAR Surgical Jumped 23.7% This WeekSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address STAA Company Calendar Last Earnings11/03/2021Today2/09/2023Next Earnings (Confirmed)2/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Ophthalmic goods Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:STAA CUSIP85231230 CIK718937 Webwww.staar.com Phone(626) 303-7902Fax626-303-2962Employees692Year Founded1982Price Target and Rating Average Stock Price Forecast$82.70 High Stock Price Forecast$125.00 Low Stock Price Forecast$60.00 Forecasted Upside/Downside+14.4%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.76 Trailing P/E Ratio95.08 Forward P/E Ratio87.06 P/E GrowthN/ANet Income$24.50 million Net Margins13.54% Pretax Margin16.66% Return on Equity15.13% Return on Assets11.90% Debt Debt-to-Equity RatioN/A Current Ratio6.55 Quick Ratio6.11 Sales & Book Value Annual Sales$230.47 million Price / Sales15.12 Cash Flow$0.66 per share Price / Cash Flow109.48 Book Value$5.43 per share Price / Book13.31Miscellaneous Outstanding Shares48,210,000Free Float46,953,000Market Cap$3.48 billion OptionableOptionable Beta1.18 Social Links Key ExecutivesThomas G. FrinziChairman, President & Chief Executive OfficerPatrick F. WilliamsChief Financial Officer & Vice PresidentKeith HollidayChief Technology OfficerScott D. BarnesChief Medical OfficerSamuel J. GestenSecretary & Chief Legal OfficerKey CompetitorsNational VisionNASDAQ:EYEWarby ParkerNYSE:WRBYBausch + LombNYSE:BLCOAbcamNASDAQ:ABCMAmicus TherapeuticsNASDAQ:FOLDView All CompetitorsInsiders & InstitutionsSwiss National BankBought 2,200 shares on 2/8/2023Ownership: 0.205%Aubrey Capital Management LtdSold 3,100 shares on 2/8/2023Ownership: 0.129%Arizona State Retirement SystemBought 478 shares on 2/8/2023Ownership: 0.024%Van ECK Associates CorpBought 1,956 shares on 2/8/2023Ownership: 0.004%Arcadia Investment Management Corp MIBought 1,600 shares on 2/8/2023Ownership: 0.004%View All Insider TransactionsView All Institutional Transactions STAA Stock - Frequently Asked Questions Should I buy or sell STAAR Surgical stock right now? 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STAA shares. View STAA analyst ratings or view top-rated stocks. What is STAAR Surgical's stock price forecast for 2023? 10 brokerages have issued 12-month price objectives for STAAR Surgical's stock. Their STAA share price forecasts range from $60.00 to $125.00. On average, they predict the company's share price to reach $82.70 in the next year. This suggests a possible upside of 14.4% from the stock's current price. View analysts price targets for STAA or view top-rated stocks among Wall Street analysts. How have STAA shares performed in 2023? STAAR Surgical's stock was trading at $48.54 on January 1st, 2023. Since then, STAA stock has increased by 48.9% and is now trading at $72.26. View the best growth stocks for 2023 here. When is STAAR Surgical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023. View our STAA earnings forecast. How were STAAR Surgical's earnings last quarter? STAAR Surgical (NASDAQ:STAA) released its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.01. The medical instruments supplier earned $58.35 million during the quarter, compared to analyst estimates of $57.70 million. STAAR Surgical had a trailing twelve-month return on equity of 15.13% and a net margin of 13.54%. During the same period last year, the firm earned $0.14 earnings per share. What guidance has STAAR Surgical issued on next quarter's earnings? STAAR Surgical issued an update on its fourth quarter 2022 earnings guidance on Tuesday, February, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $64.00 million-$64.00 million, compared to the consensus revenue estimate of $65.01 million. What is Caren Mason's approval rating as STAAR Surgical's CEO? 6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees. What other stocks do shareholders of STAAR Surgical own? Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU). What is STAAR Surgical's stock symbol? STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA." Who are STAAR Surgical's major shareholders? STAAR Surgical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (10.87%), Geneva Capital Management LLC (1.95%), Defender Capital LLC. (1.04%), APEIRON CAPITAL Ltd (0.70%), Hodges Capital Management Inc. (0.34%) and Kornitzer Capital Management Inc. KS (0.31%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten. View institutional ownership trends. How do I buy shares of STAAR Surgical? Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is STAAR Surgical's stock price today? One share of STAA stock can currently be purchased for approximately $72.26. How much money does STAAR Surgical make? STAAR Surgical (NASDAQ:STAA) has a market capitalization of $3.48 billion and generates $230.47 million in revenue each year. The medical instruments supplier earns $24.50 million in net income (profit) each year or $0.76 on an earnings per share basis. How many employees does STAAR Surgical have? The company employs 692 workers across the globe. Does STAAR Surgical have any subsidiaries? The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.Read More How can I contact STAAR Surgical? STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962. This page (NASDAQ:STAA) was last updated on 2/9/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.